RGX-121 Gene Therapy for the Treatment of Neuronopathic Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study

被引：0
|
作者：
Harmatz, Paul [1 ]
Ficicioglu, Can [2 ]
Giugliani, Roberto [3 ]
Rajan, Deepa [4 ]
Hagood, Joseph [5 ]
Fiscella, Michele [5 ]
Yang, Lin [6 ]
Gilmor, Michelle [5 ]
Cho, Yoonjin [5 ]
Phillips, Dawn [5 ]
Pisani, Laura [5 ]
Falabella, Paulo [5 ]
机构：
[1] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[2] Childrens Hosp Philadelhia, Philadelphia, PA USA
[3] Hosp Clin Porto Alegre, Porto Alegre, Brazil
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] REGENXBIO Inc, Rockville, MD USA
[6] REGENXBIO, Rockville, MD USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
807
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [31] Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data
    Giugliani, Roberto
    Martins, Ana Maria
    Okuyama, Torayuki
    Eto, Yoshikatsu
    Sakai, Norio
    Nakamura, Kimitoshi
    Morimoto, Hideto
    Minami, Kohtaro
    Yamamoto, Tatsuyoshi
    Yamaoka, Mariko
    Ikeda, Toshiaki
    So, Sairei
    Tanizawa, Kazunori
    Sonoda, Hiroyuki
    Schmidt, Mathias
    Sato, Yuji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
  • [32] MULTIPLE OPERATIONS IN INDIVIDUALS WITH MUCOPOLYSACCHARIDOSIS TYPE II (MPS II): DATA FROM THE HUNTER OUTCOME SURVEY (HOS)
    Giugliani, R.
    Bodamer, O.
    Burton, B.
    De Meirleir, L.
    Harmatz, P.
    Jones, S.
    Lampe, C.
    Malm, G.
    Parini, R.
    Steiner, R.
    Mendelsohn, N.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S128 - S128
  • [33] Genotype-phenotype findings in patients with mucopolysaccharidosis type II (MPS II): Data from the Hunter Outcome Survey
    Muenzer, Joseph
    Burton, Barbara K.
    Scarpa, Maurizio
    Botha, Jaco
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S74 - S75
  • [34] Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
    Horgan, Claire
    Jones, Simon A.
    Bigger, Brian W.
    Wynn, Robert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [35] Validation of a GMP stem cell gene therapy manufacturing process for mucopolysaccharidosis type II (MPS II) in preparation for an approved phase I/II clinical trial
    Ellison, Stuart M.
    Buckland, Karen
    Ishikawalearmonth, Yuko
    Booth, Claire
    Wynn, Robert
    Jones, Simon
    Bigger, Brian
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 39 - 39
  • [36] Long-Term Expression of HMI-203: Investigational Gene Therapy Candidate for Mucopolysaccharidosis Type II (MPS II), or Hunter Syndrome
    Smith, Laura
    Patel, Kruti
    Gingras, Jacinthe
    Tzianabos, Alec
    Schulman, Lindsay
    Zhivich, Victor
    Kivaa, Monicah
    Faulkner, Deiby
    Sengooba, Arnold
    Behmoiras, Liana
    Seabrook, Tania
    Dollive, Serena
    Avila, Nancy
    Zhao, Jingyan
    White, Yvonne
    Newman, Jenn
    Woodcock, Steve
    Smith, Sean
    Francone, Omar
    Seymour, Albert
    MOLECULAR THERAPY, 2021, 29 (04) : 247 - 247
  • [37] Characteristics of patients with mucopolysaccharidosis type II (MPS II) diagnosed aged <5 years: data from the Hunter Outcome Survey (HOS)
    Harmatz, Paul
    Lin, Shuan-Pei
    Muenzer, Joseph
    Giugliani, Roberto
    Guffon, Nathalie
    Jego, Virginie
    Burton, Barbara K.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S62 - S63
  • [38] Japan Elaprase® Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)
    Okuyama, Torayuki
    Tanaka, Akemi
    Suzuki, Yasuyuki
    Ida, Hiroyuki
    Tanaka, Toju
    Cox, Gerald F.
    Eto, Yoshikatsu
    Orii, Tadao
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (01) : 18 - 25
  • [39] Real-world data of enzyme replacement therapy with pabinafusp alfa for neuronopathic MPS-II: Updated clinical data from Japan
    Eto, Yoshikatsu
    Nakamura, Kimitoshi
    Sakai, Norio
    Tanizawa, Kazunori
    So, Sairei
    Yamamoto, Tatsuyoshi
    Ikeda, Toshiaki
    Moriuchi, Hiroaki
    Sonoda, Hiroyuki
    Sato, Yuji
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 40 - 40
  • [40] Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder
    Varga, Eszter
    Nemes, Csilla
    Kovacs, Eszter
    Bock, Istvan
    Varga, Norbert
    Feher, Anita
    Dinnyes, Andras
    Kobolak, Julianna
    STEM CELL RESEARCH, 2016, 17 (03) : 514 - 516
12345